Metropolitan Life Insurance Company (MetLife)’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,813
| Closed | -$268K | – | 2457 |
|
|
2021
Q4 | $268K | Sell |
8,813
-67
| -0.8% | -$2.11K | ﹤0.01% | 1813 |
|
|
2021
Q3 | $298K | Sell |
8,880
-293
| -3% | -$11K | ﹤0.01% | 1776 |
|
|
2021
Q2 | $366K | Buy |
9,173
+3,158
| +53% | +$124K | 0.01% | 1722 |
|
|
2021
Q1 | $270K | Sell |
6,015
-158
| -3% | -$8.81K | ﹤0.01% | 1808 |
|
|
2020
Q4 | $349K | Sell |
6,173
-135
| -2% | -$6.73K | 0.01% | 1599 |
|
|
2020
Q3 | $299K | Sell |
6,308
-148
| -2% | -$8.22K | 0.01% | 1542 |
|
|
2020
Q2 | $381K | Sell |
6,456
-2,517
| -28% | -$140K | 0.01% | 1402 |
|
|
2020
Q1 | $424K | Sell |
8,973
-283
| -3% | -$15.8K | 0.01% | 1147 |
|
|
2019
Q4 | $559K | Sell |
9,256
-172
| -2% | -$10.2K | 0.01% | 1258 |
|
|
2019
Q3 | $565K | Buy |
9,428
+228
| +2% | +$14.9K | 0.01% | 1206 |
|
|
2019
Q2 | $591K | Sell |
9,200
-213
| -2% | -$15.1K | 0.01% | 1200 |
|
|
2019
Q1 | $764K | Sell |
9,413
-197
| -2% | -$12.7K | 0.01% | 1034 |
|
|
2018
Q4 | $520K | Sell |
9,610
-31
| -0.3% | -$1.58K | 0.01% | 1172 |
|
|
2018
Q3 | $497K | Sell |
9,641
-191
| -2% | -$8.97K | 0.01% | 1353 |
|
|
2018
Q2 | $410K | Buy |
9,832
+605
| +7% | +$26.8K | 0.01% | 1454 |
|
|
2018
Q1 | $407K | Buy |
9,227
+3
| +0% | +$152 | 0.01% | 1411 |
|
|
2017
Q4 | $464K | Sell |
9,224
-88
| -0.9% | -$4.83K | 0.01% | 1341 |
|
|
2017
Q3 | $472K | Buy |
9,312
+475
| +5% | +$24.9K | ﹤0.01% | 1728 |
|
|
2017
Q2 | $450K | Buy |
8,837
+570
| +7% | +$26.5K | ﹤0.01% | 1776 |
|
|
2017
Q1 | $332K | Hold |
8,267
| – | – | ﹤0.01% | 1938 |
|
|
2016
Q4 | $395K | Sell |
8,267
-374
| -4% | -$14.8K | ﹤0.01% | 1885 |
|
|
2016
Q3 | $317K | Sell |
8,641
-414
| -5% | -$13K | ﹤0.01% | 2021 |
|
|
2016
Q2 | $211K | Buy |
9,055
+82
| +0.9% | +$2.65K | ﹤0.01% | 2287 |
|
|
2016
Q1 | $363K | Hold |
8,973
| – | – | ﹤0.01% | 1786 |
|
|
2015
Q4 | $556K | Buy |
8,973
+240
| +3% | +$12.9K | ﹤0.01% | 1553 |
|
|
2015
Q3 | $353K | Hold |
8,733
| – | – | ﹤0.01% | 1874 |
|
|
2015
Q2 | $503K | Sell |
8,733
-81,088
| -90% | -$5.16M | ﹤0.01% | 1741 |
|
|
2015
Q1 | $5.72M | Sell |
89,821
-112
| -0.1% | -$7.6K | 0.04% | 464 |
|
|
2014
Q4 | $5.55M | Buy |
89,933
+607
| +0.7% | +$30K | 0.04% | 488 |
|
|
2014
Q3 | $3.47M | Hold |
89,326
| – | – | 0.03% | 683 |
|
|
2014
Q2 | $3.08M | Hold |
89,326
| – | – | 0.02% | 791 |
|
|
2014
Q1 | $3.86M | Sell |
89,326
-181
| -0.2% | -$8.77K | 0.03% | 660 |
|
|
2013
Q4 | $3.57M | Buy |
89,507
+1,542
| +2% | +$54.9K | 0.03% | 679 |
|
|
2013
Q3 | $3.3M | Sell |
87,965
-3,518
| -4% | -$105K | 0.03% | 672 |
|
|
2013
Q2 | $2.46M | Buy |
+91,483
| New | +$1.95M | 0.02% | 772 |
|
Other funds holding IONS
BG
AIM
CCM
TBC
Metropolitan Life Insurance Company (MetLife)'s IONS Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Ionis Pharmaceuticals (IONS) in Q1 2022, closing a stake of 8,813 shares — an estimated $268K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in IONS in Q2 2013 and held it in 35 quarters. The position peaked at $5.72M in Q1 2015. 333 funds tracked by Wall St. Rank hold IONS as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Ionis Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 8,813 Ionis Pharmaceuticals shares in Q1 2022, an estimated $268K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Ionis Pharmaceuticals position peaked at $5.72M in Q1 2015.
- 333 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.